標普和納斯達克內在價值 聯繫我們
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

Daiichi Sankyo Company, Limited DSKYF OTC

Other OTC • Healthcare • Drug Manufacturers - General • JP • USD

SharesGrow Score
93/100
6/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Daiichi Sankyo Company, Limited (DSKYF) 是一家 制药 - 綜合 公司，屬於 醫療保健 產業, 目前交易價格為 $17.41. 其SharesGrow評分為 90/100, 表明 強勁 的投資特徵， 7項中通過6項.

財務數據: 營收為 $1.9T, +21.8%/yr 平均成長. 淨利潤為 $295.8B, 成長率為 +64.7%/yr. 淨利潤率為 15.7% (健康). 毛利率為 78% (+12.7 pp 趨勢).

資產負債表: 總債務為 $101.3B 對比 $1.6T 股東權益 (D/E比率 0.06, 保守). 流動比率為 2.53 (流動性強). 資產負債率為 2.9%. 總資產: $3.5T.

SharesGrow 7項標準細分: Value 100/100 (Pass), Growth 100/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 88/100 (Pass), Future ?/100 (Fail), Income 70/100 (Pass).

DSKYF SharesGrow 評分概覽

93/100
SharesGrow Score
Strong investment profile
View full scorecard →
價值 100/100
估值 — P/E, PEG, Forward PEG
成長 100/100
財務數據 — 平均成長
過去 100/100
強勁 — 趨勢
健康 100/100
資產負債表 — D/E比率, 流動比率為
護城河 88/100
毛利率為 + market cap
未來 0/100
分析師展望 — 為買入
收入 70/100
淨利潤率為
Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — DSKYF

✓
價值 Pass
100/100
DSKYF 本益比(P/E)為 N/A (S&P 500平均約25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
成長 Pass
100/100
DSKYF: +21.8%/yr 營收為, +64.7%/yr 淨利潤為 平均成長. > 5%/yr — 強勁. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
過去 Pass
100/100
DSKYF: 4 / 4 年獲利. 強勁 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
健康 Pass
100/100
資產負債表 DSKYF: D/E比率 0.06 (保守), 流動比率為 2.53 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
護城河 Pass
88/100
DSKYF: 毛利率為 78% (+12.7 pp 趨勢), $32B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 88/100. ≥ 70 = Pass.
View details →
—
未來 N/A
N/A
No analyst coverage available for this stock.
✓
收入 Pass
70/100
DSKYF: 淨利潤率為 15.7%. 健康 (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

市場數據
52週區間16.81-29.15
成交量4.96K
30日平均成交量45.5K
市值$32.23B
Beta（1年）-0.17
股息率$0.4569
Share Statistics
EPS（TTM）155.96
流通股數$1.9B
IPO Date2008-06-24
Employees18,726
CEOHiroyuki Okuzawa
Financial Highlights & Ratios
Revenue (TTM)$1.89T
Gross Profit$1.47T
EBITDA$436.13B
Net Income$295.76B
Operating Income$331.93B
Total Cash$720.73B
Total Debt$101.33B
Net Debt$-538.51B
Total Assets$3.46T
Price / Earnings (P/E)0.1
Price / Sales (P/S)0.02
Analyst Forecast
公司資訊
國家JP
交易所Other OTC
貨幣USD
ISINJP3475350009

股價走勢

Track all markets on TradingView
DSKYF
Daiichi Sankyo Company, Limited ↗  ·  Other OTC
Healthcare • Drug Manufacturers - General
16.81 52WK RANGE 29.15

其他人也在看

RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 AZNCF
AZNCF
AstraZeneca PLC
$189.90
-1.35%
 AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 GSK
GSK
GSK plc
$59.18
+0.41%
 BMY
BMY
Bristol-Myers Squibb Company
$58.08
+0.03%
 SNY
SNY
Sanofi
$47.64
+1.45%
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值，發現被低估的股票。
每週線上課程
📧 [email protected]
📞 +65 8912 8000
給我們留言